Telos
This is the archived full research. Read the story
A small Virginia contractor that sells security-compliance software, cyber work and identity checks to the US government, and enrolls travellers in TSA PreCheck.
The scores
Growth2/4 →
Up 52% in 2025 after three falling years; 2026 guided 20% to 22%, with $32M of resale leaving in 2027.
Business quality3/4 →
One of three PreCheck licences and Xacta orders renewed for years, but CLEAR enrolls at airports and the Pentagon owns eMASS.
Financial position4/4 ↑
Net cash of about $44M, no borrowing, and positive free cash flow for six quarters running.
Execution record2/4 ↑
Beat every guide since 2025, including Q3 by 9% on revenue, but revenue halved from 2021 to 2024 through three restructurings.
Per share capture2/4 ↑
Stock pay was 18% of 2025 revenue and the count rose 2.7% in six months despite buybacks.
Potential2/4 →
Growth needs bids the government has not decided and a PreCheck share nobody publishes; the DMDC work rests on Deloitte's order.
Risk profile2/4 →
The DMDC order's current period ends August 2027 and it is another company's contract; nine-tenths of revenue is federal.
Valuation1/4 ↓
About 309.5 times operating profit before depreciation, 150% of a three-stage value near $3.21 at an 8% return: priced for perfection, beyond the 20% margin.
Evidence quality3/4 →
Results, contracts and award records are filed or public; the program sizes, PreCheck share and the bids are management's word.
The Verdict
We rate Telos Unattractive. It holds one of only three licences to enroll travellers in TSA PreCheck, alongside CLEAR, and sells compliance software agencies rarely drop, but revenue halved from 2021 to 2024 before two programmes lifted it 52% in 2025, and one depends on another firm's contract, so the business is mixed. At about 23 times guided profit once share pay is counted, the price sits above our value and our best case. A $32M slice of resold products ends from late 2026, and whether $500M of bids replace it is not yet known.
The long caseTelos holds one of three PreCheck licences and sticky federal compliance software; if new awards replace the resale, a cash-rich company earns far more on less revenue.
How we weighed it
The price against our value
Against it
Price at 150% of our value
The price sits above our value and above the bull case.
The business
Cuts both ways
Mixed
A mixed business: a rare licence, but lumpy government revenue.
Growth against what the price assumes
Cuts both ways
The guide rose, but large bids are undecided and a resale contract ends.
What could go wrong
Against it
Defense identity work rides another firm's order, CLEAR competes in enrolment and the Pentagon has its own tool.
Against competitors
Cuts both ways
No filed rival compares directly, so the price is judged on its own.
How its group is behaving
Cuts both ways
Security names move together on breach and spending news.
The latest news and report
In its favour
The last report passed the test and raised the guide.
The evidence under this - 8 claims
- On 2027 consensus the price is under 8 times adjusted profit, cheap for software, if new awards replace the $33M of resale (S17, S04).
- Free cash flow of $25.9M over the twelve months to June is a 9% yield on company value, but stock pay was larger than free cash flow in 2025 (S01, S03).
- 2026-11-09editedre-struck at the 9 November close on the raised guide; the shares rose 49% on the day
- Asked whether DMDC revenue falls to $20M to $30M a year from $50M to $75M once the resale ends, the CFO declined to size the program (S04).
- Analysts' 2027 revenue of $192.0M is flat on 2026, so it already assumes new work replaces the $33M (S17).
- The timing is the customer's and has slipped before: the same bids were 'nearly $500M' due in the second half on the May call (S04).
- Funded backlog fell from $68.8M to $56.5M in the first half of 2026 (S01, S02).
- A fraction of the $500M of bids would cover the gap: $34M a year is about a fifth of it spread over three years (C16).
- The resale earns single-digit margin, so adjusted profit falls far less than revenue (C08).
- 2026-11-09editedre-struck on the raised 2026 guide, the quarterly resale headwind and the $20M of new Xacta revenue
- The $58M of orders are Xacta and services orders, not the $500M of bids: no award from the bids was named on the call or in the release.
- Management gave no 2027 guide; it said it would guide on the March call, so 2027 revenue growth is a statement of chance, not a forecast.
The company
Every federal computer system needs a formal security sign-off before it can run, and keeping that record current is a mountain of paperwork. Telos's Xacta software automates it; agencies such as the FBI, the Social Security Administration and the State Department have renewed it for years. The Pentagon's alternative is its own free tool.
Telos ID is the other half: it fingerprints and enrolls travellers for TSA PreCheck, one of three companies allowed to, and runs identity checks for agencies. A small networks unit is nearly gone.
The evidence under this - 4 claims
How it makes money
Almost all of it is government contracts: 91% of 2025 revenue came from federal agencies and 58% from the Defense Department, mostly at fixed prices. Xacta earns licence and service fees on multi-year orders. PreCheck earns a fee on each enrollment and renewal. The Defense identity program pays Telos as a subcontractor, and most of that money is for products Telos buys and resells at a thin margin.
The evidence under this - 4 claims
Neither program's revenue is filed, so the split rests on management's word; the 10-K says only 'multiple large programs in Telos ID' (S01).
Where the money comes from, stream by stream
| Stream | Share of sales (FY 2025) | How it earns it |
|---|---|---|
| Telos ID programs | not disclosed | TSA PreCheck enrollment fees, background-check channelling and the DMDC identity program, mostly resold hardware and software. |
| Xacta and cybersecurity services | not disclosed | Software licences and subscriptions for security authorizations, with consulting, assessment and the AMHS messaging system. |
| Secure Networks | 9.2% | Building and running government networks; down to about 2% of revenue in the June 2026 quarter. |
Who runs it
On 2 November 2026 Mark Griffin, with Telos since 1984, became chief executive; John Wood, who has run Telos for most of the time since 1994, became executive chairman and still owns 9.1% (directors and officers hold 14.9%). He took it public again in 2020, then revenue halved before the 2025 rebound.
Half the yearly bonus rides on new bookings and a quarter on adjusted profit. Insiders sold 1.96M shares in the past year, none under a pre-set plan, and bought none.
The evidence under this - 5 claims
- 2026-11-02editedWood stepped down as chief executive on 2 November 2026 (8-K); the holding is unchanged and his title is not
Much of it follows the October 2025 vesting of performance shares, when executives paid tax by surrendering shares; the chief executive still owns 9.1% (S08, S09).
Why it wins, and who could beat it
Why customers come back
Two things keep customers. TSA lets only three companies enroll PreCheck members, so a traveller who wants the program goes to CLEAR, IDEMIA or Telos. And an agency that keeps its security records in Xacta rarely moves them: the finance chief says it loses very little revenue to non-renewal, and federal records show the same agencies renewing for five years or more. Neither licence nor habit stops a rival already inside the gate from taking share.
The evidence under this - 4 claims
No retention figure is filed, and the Defense Department's own authorization tool, eMASS, competes inside its largest customer (S19).
The threat
CLEAR, which already has 38 million members of its own airport program, began enrolling PreCheck in 2025 and reached 61 airports within the year. On the software side, the Pentagon runs its own free authorization tool that does the job Xacta does. The networks business has already lost: its programs ended with no new wins to replace them.
The evidence under this - 3 claims
The rivals: YOU, and 3 more that are private, in-house or listed abroad.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| YOU | CLEAR's TSA PreCheck enrollmentPriced against it: Different product | Telos ID | On sale | Different product |
| Private | IDEMIA's PreCheck enrollment centersPriced against it: Private | Telos ID | On sale | Private |
| In-house | DISA's eMASSPriced against it: In-house | Xacta and cybersecurity services | On sale | In-house |
| Not listed | Large defense contractors offering secure network solutions, which the 10-K names only as a classPriced against it: Not listed | Secure Networks | On sale | Not listed |
How big it could get
How big this could get
PreCheck passed 20 million active members in 2024, each enrolled and renewed through one of three providers. Nobody publishes how many enrollments each provider takes in a year, so the members cannot be turned into a dollar figure for Telos. The software market Xacta sells into is not measured from outside at all.
The evidence under this - 2 claims
Who has signed
Deloitte holds the Defense identity order Telos works under, $487M obligated through August 2027 with options to 2029, and gave Telos a $155.6M subcontract in 2024. Xacta's buyers sign multi-year orders: the FBI, Social Security and State all run to 2027.
The evidence under this - 2 claims
Where the growth is coming from, business by business
Where the growth is coming from
| Business | Share of revenue | Growth: last quarter | Last half-year | Last year | Share in 3 years at its half-year rate |
|---|---|---|---|---|---|
| Service | 81% | +3.4% | +17.5% | +38.2% | 81% |
| Product | 19% | +28.8% | +19.0% | +72.6% | 19% |
| Whole company | 100% | +7.3% | +17.8% | +42.5% | 100% |
On the filed split through 2026-09-30, if each business keeps its last half-year's growth, the company grows about 18% next year and 18% in year 3, against 65.9% over the last twelve months. A scenario, not a forecast: no business holds its rate.
How we read it: Neither blend: the trailing rate is two program ramps that do not repeat, and the guide, the falling third quarter and the resale exit put next year well below both.
The results
The numbers
Sales grew 37% over the twelve months to Sep 2026, slower than the 52% in the year to Dec 2025.
Operating margin is −6.4%, up from −28% in the year to Dec 2023.
Running costs take 43¢ of each sales dollar, down from 53¢ in the year to Dec 2021.
Shareholders' money lost 8.6% a year, up from −28% in the year to Dec 2021.
It turned 17% of sales into free cash, $34.4M over the last twelve months.
Yearly sales growth has ranged from −33% to +52% over the last 5 years, with sales falling in 3 of them.
The share count rose 15% in 4.8 years, and pay in shares costs 7.7% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-10. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | 12 mo to Sep 2026 | |
|---|---|---|---|---|---|---|
| Size and growth | ||||||
| Sales | $242M | $217M | $145M | $108M | $165M | $197M |
| Sales growth | +35% | −11% | −33% | −26% | +52% | +37% |
| Profit | ||||||
| Gross margin | 35% | 36% | 36% | 32% | 37% | 36% |
| Operating margin | −17% | −25% | −28% | −52% | −24% | −6.4% |
| Net margin | −18% | −25% | −24% | −49% | −22% | −4.7% |
| What growth costs, per sales dollar | ||||||
| Research and development | 7.9% | 7.8% | 8.1% | 7.8% | 4.3% | 3.2% |
| Sales and marketing | 8.1% | 7.6% | 4.9% | - | - | - |
| General and admin | 37% | 46% | 56% | 70% | 48% | 32% |
| Pay in shares | 25% | 30% | 17% | 20% | 18% | 7.7% |
| Capital spending | 1.3% | 0.5% | 0.6% | 2.1% | 0.4% | 0.3% |
| Cash | ||||||
| Cash from operations | $7.26M | $16.5M | $1.59M | −$25.9M | $30.2M | $34.9M |
| Free cash flow | $4.06M | $15.5M | $661K | −$28.2M | $29.4M | $34.4M |
| Balance sheet | ||||||
| Cash and short-term investments | $127M | $119M | $99.3M | $54.6M | $53.2M | $51.8M |
| Returns and shares | ||||||
| Shares (diluted) | 66.4M | 67.6M | 69.3M | 71.8M | 72.9M | 76.5M |
What growth costs
Growth has made Telos more profitable, not less. Overheads and research fell even as revenue jumped, so the adjusted profit margin swung from a loss in 2024 to about 14% this year. Most of the new revenue came from resale and staffed enrollment sites, which cost more to deliver than software.
The evidence under this - 3 claims
Revenue was flat on the March quarter at $47.7M, so the 33% rise is the year-ago comparison, not momentum (S03).
The last report (9 Nov)
Quarter ended September 2026, filed figures.
In the September 2026 quarter revenue grew 7.3% to $55.2M, above the $49.2M to $50.6M promised. Telos earned $4.4M, its highest quarterly profit since it listed, and $7.4M of free cash flow. It raised its forecast for the year to $198M to $201M of revenue and $32M to $34M of adjusted profit.
It also won $58M of new orders for its compliance software, worth about $20M of revenue next year. On the call management said these are separate from the $500M of bids, so none of those has been awarded yet. The shares rose 49% that day.
What it did to the thesisThe test passed and the 2026 guide rose, which supports the plan. The new software orders offset part of the resale that ends, but the big bids are still undecided.
The quarter in detail
Sales growth from the previous quarter, filed figures.
Earnings per share $0.09 against $0.04 expected.
The evidence under this - 5 claims
- The $58M of orders are Xacta and services orders, not the $500M of bids: no award from the bids was named on the call or in the release.
- Management gave no 2027 guide; it said it would guide on the March call, so 2027 revenue growth is a statement of chance, not a forecast.
- The revenue range was cut at the top, and the shares fell 15.7% on the day it was given (S17).
- With the first half at $95.5M, the full-year range leaves the December quarter anywhere from about $41M to $50M, a wide spread for a company that calls most of its revenue existing programs (S03).
- 2026-11-09editedQ3 2026 release: Q3 beat the guide and the 2026 guide was raised on over $58 million of new Xacta awards, PreCheck volume and margin
- The timing is the customer's and has slipped before: the same bids were 'nearly $500M' due in the second half on the May call (S04).
- Funded backlog fell from $68.8M to $56.5M in the first half of 2026 (S01, S02).
- Asked whether DMDC revenue falls to $20M to $30M a year from $50M to $75M once the resale ends, the CFO declined to size the program (S04).
- Analysts' 2027 revenue of $192.0M is flat on 2026, so it already assumes new work replaces the $33M (S17).
What management did with the money
Telos bought back $13.6M of shares in 2025 and $6.9M in the first half of 2026, but pay in shares, $30.2M in 2025, outran it: the share count still rose 2.7% in the first half. It has no debt and pays no dividend.
Insiders in 2026Q3: 0 purchases and 8 sales, from their Form 4 filings.
The evidence under this - 2 claims
- 2026-11-09editedQ3 2026 release and 10-Q
The price, and where we disagree
In short. Priced for perfection. The price is about 150% of what we think the business is worth, at an 8% yearly return.
The shares rose 49% on 9 November, after being down by a third over the year, because Telos beat its revenue guide and raised its profit guide. Since August it has announced Xacta awards, and $58M of them arrived in the quarter.
The next few months decide the case. Management says over $500M of bids should be decided, with the revenue mainly in 2027, the year the resale ends.
The evidence under this - 4 claims
Award values in releases are usually ceilings; the HHS order shows $11.75M in USAspending against $13.7M announced (S12).
- The timing is the customer's and has slipped before: the same bids were 'nearly $500M' due in the second half on the May call (S04).
- Funded backlog fell from $68.8M to $56.5M in the first half of 2026 (S01, S02).
- The $58M of orders are Xacta and services orders, not the $500M of bids: no award from the bids was named on the call or in the release.
- Management gave no 2027 guide; it said it would guide on the March call, so 2027 revenue growth is a statement of chance, not a forecast.
How we value it
- Method
- Cash the business will produce, with any shortfall raised in new shares
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | -4.4%, 6.4% | -2.9%, 12.7% | -1.5%, 15.9% |
| Normal operating margin | 6.7% | 8.3% | 9.2% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $1.95 | $3.21 | $4.12 |
- Price
- $4.82
- Priced on
- 6 Nov
- Price as a share of the base value
- 150%
- Starting growth the price pays for
- 38.5%
- Yearly return the price offers on the base case
- 6.7%
- Risk check: valued at 12%, the rate for a business not yet making a profit
- $1.60
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last twelve months | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 9 Nov 2026; the four quarters to that date. |
| Operating margin today | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 9 Nov 2026; the four quarters to that date. |
| Tax rate | Our method's rule | The normal rate where no rate is filed to read: 25% for a US company, 21% elsewhere. |
| Sales per dollar of new capital | Our judgement | Our reading of the evidence. |
| Shares | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 9 Nov 2026; the diluted share count. |
| Cash and investments | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 9 Nov 2026; the balance sheet on that date. |
| Debt | Filed report | Quarterly report (10-Q) for the period to 30 Sep 2026, filed 9 Nov 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026 and 31 Dec 2027, as it stood when the value was struck on 10 Nov 2026: the average of 4 to 5 analysts' revenue estimates, -2.9%, 12.7%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2027, as it stood when the value was struck on 10 Nov 2026, the average of 5 analysts' estimates, less stock pay: 8.3% in the base case. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 6 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, -4% and 6%, the margin settles a fifth lower at 6.7%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue grows -3% and 13% over three years, the analysts' path (C36), then fades toward 4%, closing 30% of the gap each year; the margin moves to 8.3%, the analysts' year-three figure after stock pay.
Bull caseGrowth runs a quarter above the analysts' path, -2% and 16%, the margin reaches 9.2%, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $3.09 | $3.34 |
| The normal margin, 15% lower or higher | $2.71 | $3.70 |
| Capital per dollar of growth, a quarter more or less | $3.02 | $3.32 |
| Return on new capital after year ten, at the rate or one step up | $2.55 | $3.47 |
| The rate, a point higher or lower | $2.56 | $4.31 |
| Long-run growth a point lower | $2.89 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 6.6% | $2.41 | $2.48 | $2.55 | $2.62 | $2.71 |
| 7.5% | $2.69 | $2.78 | $2.88 | $2.98 | $3.09 |
| 8.3% | $2.98 | $3.09 | $3.21 | $3.34 | $3.47 |
| 9.1% | $3.26 | $3.39 | $3.54 | $3.69 | $3.85 |
| 10% | $3.54 | $3.70 | $3.87 | $4.05 | $4.24 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
A buyer gets no debt and real cash, but next year rests on undecided bids.
- Management now guides about $33M of adjusted operating profit before depreciation this year.
- The company is valued at about $490M after its cash, so about 15 times that.
- Counting pay in shares as a cost, it is about 23 times.
- Without new awards, 2027 revenue falls to about $167M once the resale ends; new software orders take it to about $188M.
- Analysts expected $192M before the print.
Against its own history. Buyers pay less than their normal for each dollar of sales on the last check, though the jump on the day has closed part of that gap.
The evidence under this - 4 claims
- On 2027 consensus the price is under 8 times adjusted profit, cheap for software, if new awards replace the $33M of resale (S17, S04).
- Free cash flow of $25.9M over the twelve months to June is a 9% yield on company value, but stock pay was larger than free cash flow in 2025 (S01, S03).
- 2026-11-09editedre-struck at the 9 November close on the raised guide; the shares rose 49% on the day
- A fraction of the $500M of bids would cover the gap: $34M a year is about a fifth of it spread over three years (C16).
- The resale earns single-digit margin, so adjusted profit falls far less than revenue (C08).
- 2026-11-09editedre-struck on the raised 2026 guide, the quarterly resale headwind and the $20M of new Xacta revenue
- Asked whether DMDC revenue falls to $20M to $30M a year from $50M to $75M once the resale ends, the CFO declined to size the program (S04).
- Analysts' 2027 revenue of $192.0M is flat on 2026, so it already assumes new work replaces the $33M (S17).
Priced against its rivals
None of the listed rivals above sells the same thing to the same buyers as a large part of what it does. A price comparison needs at least two, so the price is judged against its own history instead.
Also checked and set aside: Booz Allen Hamilton Holding (a substitute, not the same product).
Where we disagree with the market
Telos is a contractor whose growth rested on two programs and now stalls, with revenue guided down.
This year is covered and the lost resale earns little; next year's profit rests on unwon bids and a subcontract Deloitte controls.
The market sold the shares on a falling revenue guide in August and bought them back on a raised profit guide in November. Telos's own filings show most of the Defense program's revenue is resale, so losing it costs little profit.
The evidence against us: the real exposure is not the resale but renewals, and we cannot see whether the bids are being won or whether Deloitte's order runs past 2027.
What analysts say, and the evidence
The evidence under this - 6 claims
- 2026-11-09editedthe analyst split and short interest were not re-pulled after the print; the shares rose 49% on 9 November and the panel is due a reset
- Asked whether DMDC revenue falls to $20M to $30M a year from $50M to $75M once the resale ends, the CFO declined to size the program (S04).
- Analysts' 2027 revenue of $192.0M is flat on 2026, so it already assumes new work replaces the $33M (S17).
- The timing is the customer's and has slipped before: the same bids were 'nearly $500M' due in the second half on the May call (S04).
- Funded backlog fell from $68.8M to $56.5M in the first half of 2026 (S01, S02).
What could go wrong, and how we would know
The risks
- Someone else's contract The Defense identity work is Deloitte's order, its current period ends in August 2027, and Telos is a subcontractor Deloitte could replace.
- CLEAR in PreCheck CLEAR already has 38 million airport members and enrolled PreCheck at 61 airports within a year of starting.
- The Pentagon's own tool Defense components can keep their security records in the Pentagon's free tool instead of Xacta.
- One customer, one budget Nine-tenths of revenue is federal, so a shutdown or a stalled budget delays awards and payments.
- Insiders selling Insiders sold 1.96M shares in a year without a pre-set plan, the finance chief 480,140 since June, and nobody bought.
The evidence under this - 6 claims
Much of it follows the October 2025 vesting of performance shares, when executives paid tax by surrendering shares; the chief executive still owns 9.1% (S08, S09).
What we still do not know
- How much revenue PreCheck brings Telos, and what share of enrollments it holds; neither Telos nor TSA publishes it.
- What the Defense identity program earns once the resale ends, and whether Deloitte's order is extended past August 2027.
- Which of the $500M of bids have been won, since Defense awards are published months late.
- Whether Defense agencies are moving security records from Xacta to the Pentagon's own tool.
The evidence under this - 3 claims
Neither program's revenue is filed, so the split rests on management's word; the 10-K says only 'multiple large programs in Telos ID' (S01).
- The timing is the customer's and has slipped before: the same bids were 'nearly $500M' due in the second half on the May call (S04).
- Funded backlog fell from $68.8M to $56.5M in the first half of 2026 (S01, S02).
What would change our view
- Unattractive→NeutralThe price falls back within 20% of fair value
It needs:
- ○The share price falls to about $3.85, back within 20% of what we think the business is worth.about ≈$3.69 today, 17% below the last close
- Unattractive→AttractiveThe price falls 20% under fair value
It needs:
- ○The share price falls to about $2.57, 80% of what we think the business is worth.about ≈$2.20 today, 50% below the last close
- Unattractive→AttractiveThe bids turn into signed work
It needs all of:
- ○Telos announces awards worth more than $150M of contract value from the $500M of bids.watched as it happens
- ○The 2027 guide calls for adjusted profit above $35M.checked at the next results, due by 16 Mar
We would also be wrong if
- Free cash flow turns negative in 2026 or 2027.
- TSA authorizes a fourth PreCheck enrollment company, or Telos reports its share falling.
What is coming
- December 2026 Decisions on the $500M of bids: Whether any award from the bids above $150M of contract value is named, separate from the $58M of Xacta orders won in Q3.
Every dated event ahead
- December 2026 Decisions on the $500M of bids: Whether any award from the bids above $150M of contract value is named, separate from the $58M of Xacta orders won in Q3.
- 16 March 2027 Q4 2026 results and the 2027 guide: How much of the $33M of resale is replaced, and whether 2027 adjusted EBITDA is guided near analysts' $37M.
- 14 August 2027 IT GEMS current period ends: Whether Deloitte's DMDC order is extended toward 2029, and Telos's subcontract with it.
Since we wrote this
- 11 NovThesis reviewUnattractive, high conviction: the view holds even in our best caseConviction re-graded on the new anchors: how robust the view is, not whether anything is still open.
- 9 NovEarningsQ3 beat and raised; Xacta wins arrive; the bids are still openRevenue $55.2M beat the guide and the profit guide rose. The shares jumped 49%, so the price now pays for it; Neutral holds until the bids are decided.
- 9 NovThesis reviewUnattractive: priced at 142% of a value near $3.39Re-valued in three stages at an 8% return, the method now drawn on every thesis: the price sits beyond the 20% margin of safety.
- 3 NovNewsTelos wins a 12-month Xacta contract from the State Department, value not disclosed. View heldXacta subscription and services contract from the US Department of State.
- 2 NovNewsFounder hands the chief executive job to a 42-year insiderWood stays as executive chairman on the same pay; the view rests on the guide and bids, which this does not move.
- 6 OctThesis writtenFirst thesis: Neutral, medium confidenceProfit and cash from PreCheck and a Defense program are real, but next year rests on bids not yet won and a subcontract Deloitte controls.
Also checked 1 time with nothing new to act on.
Sources 25
Sources - 25
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-03-16the business, segments, competition classes, customer and contract mix, backlog, segment results, stock pay, the goodwill write-down, restructurings, the credit line and leasebacksC01C02C05C17C19C20C22C31C32
- S02primarycompany filing2026-08-10Q2 2026 statements, funded backlog, the revolver, share count, buybacks and the federal sharebacksC03C19
- S03primarycompany filing2026-08-10Q2 results, non-GAAP reconciliations, free cash flow, the Q3 and 2026 guidebacksC03C04C22C26C28C31C32
- S04primarytranscript2026-08-10Telos Q2 2026 earnings call transcript (FMP), held 10 August 2026the resale exit, the margin bridge, the $500M of bids, PreCheck share and the Postal Service pilot, the two large programs, the takeover question; analysts' questions from B. Riley, Needham, D.A. Davidson and Northland
Beyond 2026, the full run rate impact will be $33 million of revenue per year with only a modest impact on profit.
backsC06C08C12C16C29 - S05primarycompany filing2026-03-16Q4 and full-year 2025 results, free cash flow, buybacks and the first 2026 guidebacksC02
- S06primarytranscript2026-03-16Telos Q4 2025 earnings call transcript (FMP), held 16 March 2026Xacta renewals, the IT GEMS ramp, the confidential IT security work and the 2026 guide's build
We experience, I would say, very little to no revenue loss in a typical year on Xacta renewals
backsC06C13 - S07primarycompany filing2026-03-27ownership, pay design and outcomes, the DMDC program's resale make-up, the PreCheck site grants, the equity plan increasebacksC07C12C22C24C25
- S08primarycompany filing2026-07-24the chief executive's 9.1% holdingbacksC24
- S09primarycompany filing2026-09-21every open-market sale, the 10b5-1 flag on each, and the October 2025 vestingbacksC23
- S10primarygovernment data2026-09-29USAspending.gov: award 47QFMA24F0013 (IT GEMS) and its subawards USAspending.gov (US Treasury)the prime holder, obligated value, pricing type, current and potential end dates, and Deloitte's subaward to Telos
AWARD OF INFORMATION TECHNOLOGY GLOBAL ENTERPRISE MANAGEMENT SERVICES IT GEMS REQUIREMENT
backsC09 - S12primarygovernment data2026-10-05USAspending.gov: prime awards to Telos Corporation since 2018 USAspending.gov (US Treasury)Xacta orders at the FBI, SSA, State, the Air Force and Interior for HHS, with dates and values
XACTA ONE YEAR BRIDGE EXTENSION TO PREVIOUS ORDER 15F06720P0001661 FIRM FIXED PRICE
backsC14C15 - S13primaryregulator2026-10-06the three authorized enrollment providers (read by agent fetch; the repo's fetcher got 403)
The current enrollment providers are CLEAR, IDEMIA and Telos.
backsC10 - S14primaryregulator2024-08-08the PreCheck membership base
TSA PreCheck® Trusted Traveler program surpassed 20 million active members
backsC10 - S15primarycompany filing2026-02-25CLEAR's PreCheck enrollment launch, airports and retail sites, members, and its account of two authorized rivalsbacksC11
- S16primarycompany filing2026-05-22what a large defense contractor in Telos's competition class sells, for the cohort testread, but no claim rests on it
- S17secondaryvendor data2026-10-06Research pack (FMP and FINRA), frozen at content/TLS/research-pack.jsonprice and price history, market value, analyst split and its drift, consensus estimates, short interest, the price split, the filed revenue seriesbacksC05C23C27C28
- S18primarycompany release2026-10-05four Xacta awards and their announced values
Three-year award provides Xacta license maintenance, training and cyber services for Air Force ISR systems
backsC15 - S19secondarygovernment data2026-10-06what eMASS is and that the government owns it
a web-based Government off-the-shelf (GOTS) solution that automates a broad range of services for comprehensive, fully-integrated cybersecurity management
backsC18 - S20tertiaryother2026-10-06Wikipedia: eMASS WikipediaDoD ownership and its role as the recommended authorization tool
eMASS is owned by the U.S. Department of Defense (i.e., the software is not proprietary).
backsC18 - S21primarycompany filing2026-11-02the succession, Griffin's terms and the unchanged terms for WoodbacksC24C33
- S22primarycompany filing2026-11-09Q3 results, non-GAAP reconciliations, free cash flow, the $58M of Xacta orders, the raised fourth-quarter and 2026 guidebacksC04C21C26C30C34C35
- S23primarycompany filing2026-11-09funded backlog, federal revenue concentration, cash, share repurchases and the credit line extensionbacksC17C20C21C34
- S24primarytranscript2026-11-09Telos Q3 2026 earnings call transcript (FMP)the $58M of Xacta wins as recurring and separate from the $500M of bids, the quarterly size of the 2027 resale headwind, the margin lifts, and analyst questions from D.A. Davidson, B. Riley, Needham and Northland
So the elimination of the IT GEMS third-party software, that should give us about 600 basis points of gross margin lift on a full year run rate basis. And then in addition, TSA PreCheck in the second half of 2027, we're expecting about 400 basis points of sequential margin improvement from the first half of '27 to the second half of '27.
backsC30C35 - S25primarycompany filing2026-11-09trailing revenue, operating profit, stock pay, tax, debt, cash and the diluted share countbacksC37
- S26secondaryvendor data2026-11-09the analysts' average revenue and operating profit for the next three fiscal years, and the closebacksC36C37